Cybille Delacroix Muirhei

Array ( [id] => 1228489 [patent_doc_number] => 06696417 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-24 [patent_title] => 'Skin and hair darkening composition' [patent_app_type] => B1 [patent_app_number] => 09/191974 [patent_app_country] => US [patent_app_date] => 1998-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1989 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/696/06696417.pdf [firstpage_image] =>[orig_patent_app_number] => 09191974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4190915 [patent_doc_number] => 06153647 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Method for augmenting the inotropic effects of .beta.-adrenergic agonists using pyruvate therapy' [patent_app_type] => 1 [patent_app_number] => 9/190814 [patent_app_country] => US [patent_app_date] => 1998-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3241 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153647.pdf [firstpage_image] =>[orig_patent_app_number] => 190814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356034 [patent_doc_number] => 06200955 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Heparin binding peptides' [patent_app_type] => 1 [patent_app_number] => 9/166930 [patent_app_country] => US [patent_app_date] => 1998-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 13146 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200955.pdf [firstpage_image] =>[orig_patent_app_number] => 166930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440429 [patent_doc_number] => 06495591 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Fungal efflux pump inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/164609 [patent_app_country] => US [patent_app_date] => 1998-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 39 [patent_no_of_words] => 17685 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495591.pdf [firstpage_image] =>[orig_patent_app_number] => 09164609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4105825 [patent_doc_number] => 06051694 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Method for size reduction of proteins' [patent_app_type] => 1 [patent_app_number] => 9/156197 [patent_app_country] => US [patent_app_date] => 1998-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4379 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051694.pdf [firstpage_image] =>[orig_patent_app_number] => 156197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4193137 [patent_doc_number] => 06043252 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Carboline derivatives' [patent_app_type] => 1 [patent_app_number] => 9/154052 [patent_app_country] => US [patent_app_date] => 1998-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41344 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 683 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/043/06043252.pdf [firstpage_image] =>[orig_patent_app_number] => 154052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237512 [patent_doc_number] => 06143746 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use' [patent_app_type] => 1 [patent_app_number] => 9/154051 [patent_app_country] => US [patent_app_date] => 1998-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30321 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143746.pdf [firstpage_image] =>[orig_patent_app_number] => 154051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237703 [patent_doc_number] => 06143757 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Chemical compounds' [patent_app_type] => 1 [patent_app_number] => 9/154619 [patent_app_country] => US [patent_app_date] => 1998-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16362 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 285 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143757.pdf [firstpage_image] =>[orig_patent_app_number] => 154619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4082449 [patent_doc_number] => 06054461 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Treatment of neuropathic pain' [patent_app_type] => 1 [patent_app_number] => 9/152343 [patent_app_country] => US [patent_app_date] => 1998-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3471 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054461.pdf [firstpage_image] =>[orig_patent_app_number] => 152343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4141474 [patent_doc_number] => 06060499 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Anti-migraine methods and compositions using 5-HT agonists with long-acting NSAIDs' [patent_app_type] => 1 [patent_app_number] => 9/151912 [patent_app_country] => US [patent_app_date] => 1998-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6987 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060499.pdf [firstpage_image] =>[orig_patent_app_number] => 151912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4396391 [patent_doc_number] => 06297214 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-02 [patent_title] => 'Methods of enhancing functioning of the large intestine' [patent_app_type] => 1 [patent_app_number] => 9/149831 [patent_app_country] => US [patent_app_date] => 1998-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 8348 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/297/06297214.pdf [firstpage_image] =>[orig_patent_app_number] => 149831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7027843 [patent_doc_number] => 20010014349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-16 [patent_title] => 'COMPOSITION CONTAINING A NERVE FIBRE REACTIVITY MODULATING COMPOUND' [patent_app_type] => new [patent_app_number] => 08/983125 [patent_app_country] => US [patent_app_date] => 1998-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2250 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20010014349.pdf [firstpage_image] =>[orig_patent_app_number] => 08983125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4209669 [patent_doc_number] => 06110476 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'System for stabilizing ascorbic acid based on a phosphonic acid derivative and on a metabisulfite' [patent_app_type] => 1 [patent_app_number] => 9/145454 [patent_app_country] => US [patent_app_date] => 1998-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2820 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110476.pdf [firstpage_image] =>[orig_patent_app_number] => 145454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4421261 [patent_doc_number] => 06177476 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Nutritional supplements for replenishing plasmalogens' [patent_app_type] => 1 [patent_app_number] => 9/141061 [patent_app_country] => US [patent_app_date] => 1998-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4325 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177476.pdf [firstpage_image] =>[orig_patent_app_number] => 141061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383314 [patent_doc_number] => 06277846 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Use of platelet activating factor antagonists as anti-pruritic agents' [patent_app_type] => 1 [patent_app_number] => 9/138967 [patent_app_country] => US [patent_app_date] => 1998-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3771 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277846.pdf [firstpage_image] =>[orig_patent_app_number] => 138967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4292738 [patent_doc_number] => 06235784 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Medicament and therapeutical method for treating idiopathic asthenozoospermia' [patent_app_type] => 1 [patent_app_number] => 9/132427 [patent_app_country] => US [patent_app_date] => 1998-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1969 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235784.pdf [firstpage_image] =>[orig_patent_app_number] => 132427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3912578 [patent_doc_number] => 06001807 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Use of CRF-antagonists for treating emesis' [patent_app_type] => 1 [patent_app_number] => 9/131980 [patent_app_country] => US [patent_app_date] => 1998-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1127 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001807.pdf [firstpage_image] =>[orig_patent_app_number] => 131980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355813 [patent_doc_number] => 06218383 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Pharmaceutical compositions for the prevention and treatment of central nervous system disorders' [patent_app_type] => 1 [patent_app_number] => 9/130498 [patent_app_country] => US [patent_app_date] => 1998-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5598 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218383.pdf [firstpage_image] =>[orig_patent_app_number] => 130498 [rel_patent_id] =>[rel_patent_doc_number] =>)